Apogee Acquisition

This filing locks the foundational trust balance, public share count, and deadline timeline that dictate redemption economics for public investors. The disclosed $173,362,500 trust deposit ($10.05 per Unit) establishes the baseline cash reserve available for shareholder redemptions absent a merger by July 8, 2027. Confirming full over-allotment exercise expands the public float and triggers the agreed-upon Founder Share forfeiture mechanics to preserve the 25% sponsor economic stake. Disclosed monthly cash drains—a $10,000 administrative fee payable to the sponsor and a $6,000 Chief Financial Officer fee payable to Brio Financial Group—clarify pre-combination operating expenses outside the trust, directly influencing the interest accumulation trajectory. Contractual waivers by the sponsor and directors relinquishing any claim to the trust account, paired with standard lock-up restrictions and binding proxy/voting commitments, materially align insider incentives with public shareholder returns during the active search phase.

This filing defines the complete economic framework, redemption mechanics, governance constraints, and sponsor incentive alignment for investors before trading begins. It confirms the $10.05 per-share trust funding mechanism and clarifies that public shareholders face no net tangible asset floor for redemptions, while imposing a 15% group-level cap outside tender offers.

The explicitly stated $10.05 per-share trust floor and the contracted 15-month search window define the baseline liquidity horizon and liquidation expectations for public investors ahead of a potential de-SPAC transaction. The sponsor’s nominal $0.003 acquisition cost for founder shares, combined with contractual anti-dilution conversion provisions guaranteeing founders represent 25% of outstanding shares post-offering, structurally aligns insider incentives to pursue any business combination regardless of whether public share returns fall below the initial trust amount. The recent amendment compressing the completion timeline from 18 months to 15 months intensifies execution pressure while preserving unconditional public redemption rights upon any charter extension, ensuring shareholders maintain downside protection. Finally, the restructuring of the offering units from a half-warrant arrangement to a single full warrant plus a 1/5 share right, alongside the explicit renunciation of corporate opportunities by officers and directors, fundamentally alters the post-listing capital structure and mitigates formal fiduciary friction between the sponsor-managed entity and the public shareholders.

Deferring the acceleration timeline extends the pre-effectiveness period, keeping capital off the balance sheet and postponing investor redemption windows. This pacing decision reflects management’s preference under standard SEC review rather than expedited processing, altering the expected cadence of capital deployment without changing the long-dated liquidation cliff. No operational, financial, or strategic claims regarding customers, revenue, market size, technology, partnerships, or litigation appear in the text.

Withdrawing an acceleration request typically indicates that the issuer or underwriters are halting execution to revise offering terms, address regulatory feedback, or recalibrate to market conditions before pricing. For investors monitoring deal progress, the delay postpones capital formation and subsequent target acquisition without shifting the contractual expiration window of 2027-07-08 or changing the $10.05 per-share trust reserve.

Clearing the S-1 acceleration moves the capital-raising mechanism forward, which is a prerequisite for funding the ongoing business combination search. Because the letter contains no disclosures regarding target acquisition, transaction pricing, sponsor conduct adjustments, or trust account modifications, it advances administrative timelines without altering investor economics or redemption windows. All structural parameters remain tethered to previously submitted prospectus filings.

The filing definitively sets the redemption economics and dilution profile for public investors relative to insiders. It confirms the sponsor will purchase 470,000 private placement units simultaneously, while up to 1,250,000 founder shares are forfeitable to preserve a 25% collective insider stake. Critically, it documents recurring operational cash drains totaling $16,000 monthly ($10,000 paid to Apogee Acquisition Sponsor LLC for office/administrative services; $6,000 paid to Brio Financial Group for CFO Ian Rhodes' services) against only $850,000 in non-trust working capital, highlighting the tight runway and reliance on potential working capital loans. The prospectus also catalogs extensive fiduciary overlaps among management and directors across multiple active SPACs and operating companies, establishing a clear conflict-of-interest landscape that governs target sourcing urgency and allocation decisions before the 15-month expiration.

Stripping away the cash-deposit extension right and compressing the operational horizon significantly elevates liquidation risk, forcing management to prioritize speed over due diligence while simultaneously removing a traditional safety valve that historically prolonged SPAC lifecycles. Tightening permissible trust withdrawals safeguards the $10.00 per-share liquidity threshold against internal cash drains, directly protecting redeeming shareholders from working capital bleed. However, because the sponsor's equity was effectively issued at roughly $0.003 per share and is locked behind mathematical protections that guarantee a 25% retained stake regardless of how many public shares are sold back, minority investors bear asymmetric dilution risk; if redemptions fall short, public holders will absorb disproportionate earnings dilution and value erosion upon a business combination or forced wind-down.

By declining to review the draft S-1, the SEC staff effectively removes the standard comment period, which typically accelerates the path to effectiveness and allows the sponsor to advance a merger or business combination on a shorter timeline. The staff’s insistence on a 15-day advance public filing window and the repeated liability warning signal that while regulatory friction is reduced, management faces uncompromising enforcement risk for any misstatements.

Investors receive a definitive view of the economic floor, dilution pathways, and timeline before any target identification or market pricing occurs. The explicit removal of a net tangible asset floor eliminates structural barriers to full cash redemptions, directly dictating how much capital remains for public shareholders if the Sponsor targets a highly redeemable deal. The 24-month deadline creates a hard chronometer for execution, while the extension mechanism introduces conditional liquidity events.

What changed: Schedule 13G — beneficial ownership report. The filing identifies Highbridge Capital Management, LLC as the reporting holder. The excerpt contains no data regarding redemption mechanics, trust account status, extension procedures, target acquisition progress, or sponsor conduct. It includes no statements regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: As a routine compliance exhibit triggered by statutory ownership thresholds, this Schedule 13G updates the public record of institutional shareholding but provides no quantifiable metrics for trust distributions, redemption pricing, or deal timelines. Without disclosed percentages, amendment dates, or transaction details, the filing does not indicate imminent liquidity events or governance shifts. Subsequent SEC filings will determine whether Highbridge Capital Management, LLC’s stake crosses additional reporting thresholds or influences future trustee or sponsor directives.

What changed: Routine compliance exhibit: a Schedule 13G joint filing agreement filed pursuant to Section 13(d) of the Securities Exchange Act of 1934 and Rule 13d-1(k). Mechanics impact: Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman jointly registered their beneficial ownership of Apogee Acquisition Corp. shares as of June 30, 2026, with the agreement executed on August 13, 2026 by Attorney-in-Fact Hayley Stein. The filing contains no share counts, acquisition or disposition dates, percentage thresholds, or explicit statements regarding shareholder redemption behavior, trust account liquidity, extension voting intent, target pipeline development, or sponsor fiduciary conduct. It functions solely as a static regulatory snapshot under previsions of Rule 13d-1(k). Why it matters: Other substance: The attached Exhibit 99.1 clarifies the authorized signatory chain among the four Magnetar-affiliated holders, designating Hayley Stein as Attorney-in-Fact for each entity. As stated by the undersigned filers, the report reflects holdings at the close of Q2 2026. Because the schedule lacks quantitative position data and transactional history, it delivers no predictive input for the July 8, 2027 business combination deadline, the prevailing $10.13 per-share trust balance, or near-term redemption windows. For investors monitoring the SEARCHING-status SPAC, the filing anchors a known institutional shareholder base but offers no actionable intelligence on deal momentum, sponsor alignment, or capital preservation efforts. Any shift in influence or intent would require a follow-up amendment disclosing numeric changes or purpose-of-investment updates.

What changed: Schedule 13G beneficial ownership report. The filing identifies Glazer Capital, LLC and Paul J. Glazer as reporting beneficial owners of AACP securities. It contains no share quantities, acquisition dates, or dollar amounts, and makes no reference to redemption windows, trust account balances, extension procedures, target deal progress, or sponsor conduct. Why it matters: As a routine regulatory disclosure, the Schedule 13G formally records that these parties hold a stake triggering SEC transparency requirements. Monitoring which firms and individuals register beneficial ownership during Apogee Acquisition’s search phase allows investors to track concentration of voting weight and anticipate which shareholders may later influence extension approvals, redemption elections, or a business combination vote, though the excerpt does not disclose strategic intent, capital commitments, or partnership arrangements.

What changed: routine compliance exhibit / beneficial ownership report (Schedule 13G). KARPUS MANAGEMENT, INC. filed the submission to disclose institutional beneficial ownership. The filing text contains no provisions, notices, or disclosures regarding redemption deadlines, trust account values, extension votes, target identification progress, or sponsor conduct. Why it matters: Schedule 13G filings are standardized regulatory disclosures triggered when beneficial ownership crosses specified thresholds; they serve solely to inform the Commission of equity positions and carry no operative effect on a SPAC's liquidation timeline, trust preservation, merger search, or management accountability. Investors monitoring redemption windows, trust distributions, or sponsor actions will find no material shift in this report.

What changed: A Form 8-K current report filed on May 22, 2026. The filing and attached press release announce that beginning May 28, 2026, holders of the company’s initial public offering units may elect to separately trade the underlying Class A ordinary shares, warrants, and rights. Each unit consists of one Class A ordinary share with a par value of $0.0001 per share, one redeemable warrant exercisable at an exercise price of $11.50 per share, and one right entitling the holder to acquire one-fifth (1/5) of one Class A ordinary share upon completion of an initial business combination. Separated shares, warrants, and rights will trade on Nasdaq under the symbols AACP, AACPW, and AACPR, respectively, while unseparated units continue under AACPU. The company directed shareholders to have their brokers contact Efficiency INC., the designated transfer agent, to facilitate the separation. Why it matters: This event modifies the post-IPO capital structure and trading mechanics without changing the trust account balance, redemption timeline, or the company’s search status. The press release attributes to management a strategic focus on acquiring companies in software, hardware, compute infrastructure, engineered materials, intelligent systems, automation, specialized components, energy and power technologies, and other technology-driven platforms. Chief Executive Officer Jeffrey Smith, JD, LLM, executed the report. The filing discloses no updates on target identification, deal negotiations, extension mechanisms, sponsor contributions, or redemption thresholds.

What changed: a routine compliance exhibit. According to management disclosures in the filing, the substantive update concerns subsequent events finalized after the March 31, 2026 reporting period. The company confirmed that on April 8, 2026, it consummated its Initial Public Offering of 17,250,000 units at $10.00 per unit, yielding $172,500,000 in public proceeds. Alongside a simultaneous private sale to the Sponsor for 470,000 units at $10.00 per unit totaling $4,700,000, the underwriters fully exercised their 45-day over-allotment option for 2,250,000 units. Accordingly, $173,362,500 ($10.05 per unit) was deposited into the Trust Account. Furthermore, on March 31, 2026, the Sponsor surrendered 3,833,333 founder shares, resulting in 5,490,000 founder shares remaining outstanding, with 50,000 allocated to each independent director nominee and 60,000 to the Chief Operating Officer. Why it matters: These subsequent transactions formally activate the statutory search timeline, initiating the 15-month Combination Period from the April 8, 2026 closing date and fixing the liquidation expiration to approximately July 8, 2027. The $10.05 per-unit Trust valuation establishes the definitive, non-negotiable redemption floor for public shareholders, superseding any pre-offering estimates. The Sponsor's voluntary surrender of 3,833,333 founder shares dramatically curtails potential post-merger dilution and signals heightened capital alignment. Meanwhile, the disclosed $55,000 in quarterly formation expenses quantifies the baseline operational burn rate during the pre-acquisition due diligence phase.

What changed: Joint Filing Agreement (Exhibit 99.1) to a Schedule 13D, executed April 15, 2026, by Apogee Acquisition Sponsor LLC through Managing Member Jeffrey Smith, authorizing coordinated regulatory submission under Rule 13d-1(k) for Apogee Acquisition Corp. ordinary shares ($0.0001 par value). This exhibit contains no share counts, purchase prices, ownership percentages, tender instructions, or extension requests. Consequently, the SPAC’s trust valuation remains at $10.13 per share, the initial business combination deadline remains July 8, 2027, and the entity maintains SEARCHING status. The document does not alter redemption windows, liquidation triggers, or deal timelines. Its only operative change is establishing that each reporting party accepts sole responsibility for the accuracy and completeness of their own information within the joint Schedule 13D filing, with no shared liability for co-reporters’ data unless actual knowledge of inaccuracy exists. Why it matters: Investors tracking sponsor conduct should recognize that Apogee Acquisition Sponsor LLC has entered a joint disclosure arrangement with the signing date of April 15, 2026, signaling potential multi-entity coordination as the July 8, 2027 deadline approaches. Because the accompanying Schedule 13D statement disclosing actual stake size, acquisition cost, and stated purpose is omitted from this extract, the filing provides no actionable signal regarding tender pressure, activist positioning, or merger negotiations. The absence of claimed customers, revenue figures, market sizing, strategic roadmap, technology assets, partnership contracts, litigation posture, or personnel appointments means the document contributes zero operational or financial substance. Continued monitoring of subsequent 13D amendments will be required to determine whether the sponsor is accumulating shares for a pending de-SPAC, managing internal holding structures, or preparing a formal solicitation prior to the July 2027 cutoff.

What changed: A routine compliance exhibit and regulatory filing — specifically a Schedule 13G beneficial ownership report accompanied by Exhibit 99.A, a Joint Filing Agreement executed pursuant to Rule 13d-1(k). According to the exhibit dated April 14, 2026, the listed Harraden Circle investment vehicles and Frederick V. Fortmiller, Jr. formally agreed to consolidate their beneficial ownership disclosures in Apogee Acquisition Corp onto a single shared Schedule 13G. The filing explicitly states that any future amendments, including those filed on Schedule 13D, will be submitted on behalf of each signatory through this joint arrangement. No alterations to acquisition objectives, sponsor governance, redemption mechanics, trust accounting, or the business combination timeline are disclosed or triggered by this submission. Why it matters: The joint filing agreement centralizes reporting obligations and signals that voting directives, redemption decisions, and any subsequent equity transactions for these affiliated vehicles are coordinated under Mr. Fortmiller’s Managing Member authority. For investors tracking the redemption calendar and blockholder alignment, this confirms a unified institutional position rather than fragmented independent holders, though the document contains no operational claims regarding customer concentrations, revenue, market size, strategic pivot, technology, partnerships, or litigation. Because the exhibit serves exclusively as an administrative aggregation of existing holdings and a procedural acknowledgment of joint rule compliance, it does not shift trust distribution parameters, propose an extension, indicate target engagement, or modify sponsor conduct expectations.

What changed: Form 8-K Current Report announcing the consummation of an initial public offering and attaching an audited balance sheet as Exhibit 99.1. According to Item 8.01, Apogee Acquisition Corp consummated its IPO on April 8, 2026, selling 17,250,000 units at $10.00 per unit, which includes the full exercise of the underwriters' 2,250,000-unit over-allotment option. Simultaneously, the company completed a private placement of 470,000 units to Apogee Acquisition Sponsor LLC for $4,700,000. The filing states that $173,362,500 ($10.05 per Unit) of net proceeds, including $6,000,000 in deferred underwriting commissions, was placed into a trust account managed by Efficiency INC. Note 1 specifies a 15-month Combination Period, establishing a fixed liquidation deadline of July 8, 2027, absent a shareholder-approved extension. The attached audited balance sheet confirms $173,362,500 in cash held in trust and $738,926 in unrestricted operating cash. Why it matters: This filing establishes a definitive trust value of $10.05 per public share, immediately resetting investor redemption baselines above the industry standard $10.00 benchmark and dictating the maximum liquidation payout. The confirmed full over-allotment exercise eliminates any over-allotment-related forfeiture risk for the sponsor's founder shares and caps the public float at 17,250,000 shares. The explicit 15-month timeline locks the redemption deadline to July 8, 2027, forcing investors to monitor extension proposals closely. Furthermore, the disclosure of $8,972,198 in total transaction costs, a $6,000,000 deferred underwriting liability, and a $10,000 monthly sponsor administrative fee alongside a $6,000 monthly outsourced CFO arrangement outlines the structural cost drag and sponsor compensation mechanics that must be funded before a business combination closes.

What changed: Form 8-K Current Report confirming IPO consummation and attaching related definitive offering agreements. According to the filed 8-K and press releases dated April 6 and April 8, 2026, Apogee Acquisition closed its IPO on April 8, 2026, issuing 17,250,000 units at $10.00 per unit after the underwriters fully exercised their over-allotment option. Gross proceeds reached $172,500,000, with $173,362,500 ($10.05 per Unit) deposited into the trust account. The firm liquidation deadline is set for July 8, 2027. Simultaneously, the sponsor purchased 470,000 private placement units for $4,700,000. The registrant states that new directors Anna Brunelle, David Quiram, Sagiv Shiv, and Christopher Valentine joined CEO and Chairman Jeffrey Smith. Company representatives explicitly note it has not selected any specific target business or engaged in substantive discussions regarding a potential transaction. Why it matters: This filing locks the foundational trust balance, public share count, and deadline timeline that dictate redemption economics for public investors. The disclosed $173,362,500 trust deposit ($10.05 per Unit) establishes the baseline cash reserve available for shareholder redemptions absent a merger by July 8, 2027. Confirming full over-allotment exercise expands the public float and triggers the agreed-upon Founder Share forfeiture mechanics to preserve the 25% sponsor economic stake. Disclosed monthly cash drains—a $10,000 administrative fee payable to the sponsor and a $6,000 Chief Financial Officer fee payable to Brio Financial Group—clarify pre-combination operating expenses outside the trust, directly influencing the interest accumulation trajectory. Contractual waivers by the sponsor and directors relinquishing any claim to the trust account, paired with standard lock-up restrictions and binding proxy/voting commitments, materially align insider incentives with public shareholder returns during the active search phase.